| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.85B | — | +49.0% |
| Cost of Revenue | $4.98B | — | +57.5% |
| Gross Profit | $3.86B | — | +39.4% |
| R&D Expense | $699.0M | — | +26.9% |
| SG&A Expense | $326.0M | — | +27.8% |
| Operating Income | $611.0M | — | -19.9% |
| Pre-tax Income | $579.0M | — | -18.0% |
| Income Tax | $162.0M | — | -23.6% |
| Net Income | $417.0M | — | -15.6% |
| EPS (Basic) | $8.23 | — | -15.5% |
| EPS (Diluted) | $8.23 | — | -15.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.68B | +0.2% | +23.5% |
| Short-term Investments | $1.97B | -25.0% | -61.2% |
| Accounts Receivable | $370.0M | +0.3% | +41.8% |
| Inventory | $677.0M | +18.8% | +89.1% |
| Current Assets | $37.12B | +10.6% | +70.8% |
| Total Assets | $46.93B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.08B | — | +101.3% |
| Investing Cash Flow | -$1.47B | — | +20.1% |
| Financing Cash Flow | $473.0M | — | +1.7% |
| +69.5% |
| Current Liabilities | $31.97B | +11.7% | +77.0% |
| Long-term Debt | $9.93B | +8.0% | +54.3% |
| Total Liabilities | $39.65B | +10.4% | +74.9% |
| Stockholders' Equity | $7.28B | +7.9% | +45.5% |